Background
Echoviruses are members of the Enterovirus genus in the Picornaviridae family. They make up the largest Enterovirus subgroup, consisting of 32 serotypes.[1] Echoviruses are common human pathogens that cause a range of illnesses, from minor febrile illness to severe, potentially fatal conditions (eg, aseptic meningitis, encephalitis, paralysis, myocarditis).[2, 1] Individual serotypes have different temporal patterns of circulation and cause different clinical manifestations. Changes in circulating serotypes can be associated with large scale outbreaks.[2]
Enteroviruses are divided into 5 subgenera: polioviruses, group A coxsackieviruses, group B coxsackieviruses, echoviruses, and the newer enteroviruses. Each subgenus contains numerous unique enterovirus serotypes differentiated based on neutralization of specific antisera.[3]
The term enterovirus reflects enteric transmission of the virus via person-to-person spread. ECHO is an acronym for enteric cytopathic human orphan.
Echoviruses were first isolated from the feces of asymptomatic children in the context of epidemiological studies of polioviruses. The viruses produced cytopathic effects in cell cultures but failed to cause detectable pathologic lesions in suckling mice.[4] Most echoviruses are no longer considered orphans.
Echoviruses were originally classified into 34 serotypes. Echovirus 10 and 28 have been reclassified as reoviruses, and echovirus 9 is now recognized as the same as coxsackievirus A23.[2]
Echoviruses are small nonenveloped viruses with an icosahedral configuration. A capsid composed of 60 subunits is formed from 4 proteins—VP1 to VP4. These proteins play important roles in terms of determining host range and tropism and in delivering the RNA genome into the cytoplasm of the host's cells. Echoviruses are infective over a wide range of pH (3-10) and are resistant to ether and alcohol.[5]
Pathophysiology
Human echoviral infection occurs via fecal-oral transmission. Host susceptibility depends on the presence of specific cellular membrane receptor proteins that bind different enteroviral types along taxonomic lines. Decay-accelerating factor (DAF) appears to be a major echovirus receptor, binding many echovirus serotypes, including 6, 7, 11, 12, 20, 21, 29, and 33. Echovirus serotypes 1 and 8 bind a subunit of the very late antigen (VLA) integrin molecule.
Following ingestion of fecally contaminated material, viral replication begins in the pharynx or gut. The precise site of viral entry and initial replication in the GI tract is not well established, but researchers have demonstrated the presence of enteroviruses in mucosal M cells. Ileal lymphoid tissue demonstrates enteroviral replication within 1-3 days after ingestion. The maximal duration of viral excretion is 3-4 weeks in the pharynx and 5-6 weeks in stool.
Following replication, enteroviruses spread to regional lymph nodes and cause subclinical transient viremia. During this low-grade viremia, the virus spreads to reticuloendothelial tissues, including the liver, spleen, bone marrow, and distant lymph nodes. Secondary sites of infection include the CNS, liver, spleen, bone marrow, heart, and lungs. More than 90% of echoviral infections are asymptomatic. When disease occurs, symptoms vary from undifferentiated febrile illness to severe illness, depending on the age, gender, and immune status of the host and the subgroup, serotype, and enteroviral strain.[6]
For additional information, please also refer to eMedicine's Enterovirus topic.
Epidemiology
Frequency
United States
Echoviruses are common and are associated with both epidemic and endemic patterns of infection in individuals of all ages.[7] The voluntary and passive nature of viral illness reporting complicates the true estimate of disease.[2] Serologic surveys are not feasible because of the large number of nonpoliovirus serotypes.
In temperate climates, enteroviral activity peaks during the summer and early fall.[8] Serotype-based surveillance provides a mechanism for determining patterns of circulation and for identifying predominant serotypes.[2] Changes in predominant serotypes can be associated with large-scale outbreaks of enteroviral illnesses. In 2005, the National Enterovirus Surveillance System (NESS) reported that the 15 most common enteroviruses accounted for 83.5% of reports with identified serotypes. The 5 most common serotypes were echoviruses 9, 11, 30, and 6 and coxsackievirus B5, accounting for 48.1% of reported cases.
In the United States, peaks in nationwide hospitalization for aseptic meningitis have been observed in years when echovirus 9 was predominant. Echovirus 9 was the most commonly reported enterovirus from 1970-2005 and accounted for 11.8% of reports with known serotypes.[2]
International
Echoviruses are found worldwide and affect people of all races and cultures. Infection rates vary with the season, geography, and the age and socioeconomic status of the population sampled. Infection among lower socioeconomic groups is attributed to overcrowded living conditions and poor hygiene.[9] Infections occur throughout the year in tropical climates. In temperate climates, infections are more prevalent during the summer and early fall.[9]
Epidemics have been reported in Panama, Mexico, Switzerland, Cuba, the United States, and Turkey. Asian-Pacific countries have reported major enteroviral epidemics with significant morbidity and mortality. A Thai hospital reported the first nosocomial outbreak of hand-foot-and-mouth disease due to echovirus type 11, underscoring the importance of strict infection control and hand washing in preventing disease.[10] A similar outbreak of echovirus 11 was reported from an Israeli children's home. Nine children shared a large room with a common basin. Three children presented with aseptic meningitis, and all had stool cultures positive for echovirus 11.[9]
Race
Echovirus infection has no racial predilection.
Sex
For unclear reasons, males are at greater risk for clinical illness following infection, by as much as 50%.[11] Aseptic meningitis is nearly twice as common in boys as in girls. After puberty, the reverse appears to be true, perhaps because women tend to have more exposure to children who are shedding the virus. Pregnancy also appears to enhance the severity of enteroviral infections.
Age
Three quarters of enteroviral infections, including echoviral infections, reported to the World Health Organization occur in children younger than 15 years. In the United States, attack rates in infants younger than 1 year greatly exceed those in older children and adults.[12, 13] Children younger than one year accounted for 44.2% of reported cases. A male predominance was noted among patients younger than 20 years, but not among patients aged 20 years or older.[2]
Dahllund L, Nissinen L, Pulli T, Hyttinen VP, Stanway G, Hyypiä T. The genome of echovirus 11. Virus Res. Feb 1995;35(2):215-22. [Medline].
Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Enterovirus surveillance--United States, 1970-2005. MMWR Surveill Summ. Sep 15 2006;55(8):1-20. [Medline]. [Full Text].
Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol. Mar 2000;38(3):1170-4. [Medline].
Echoviruses of Enteroviruses Infection. virology-online.com. Available at http://virology-online.com/viruses/Enteroviruses6.htm. Accessed 8/31/09.
Ruecker RR. Picornaviridae and their replication. In: Fields BN, Knipe DM, eds. Virology. 2nd ed. New York: Raven Press; 1990:507.
Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol 2. 6th ed. Philadelphia, PA: Elsevier Inc.; 2005:2148-61.
Kupila L, Vuorinen T, Vainionpäa R, Marttila RJ, Kotilainen P. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis. Apr 1 2005;40(7):982-7. [Medline].
Centers for Disease Control and Prevention (CDC). Aseptic meningitis outbreak associated with echovirus 9 among recreational vehicle campers--Connecticut, 2003. MMWR Morb Mortal Wkly Rep. Aug 13 2004;53(31):710-3. [Medline]. [Full Text].
Somekh E, Shohat T, Handsher R, Serour F. An outbreak of echovirus 11 in a children's home. Epidemiol Infect. Jun 2001;126(3):441-4. [Medline].
Apisarnthanarak A, Kitphati R, Pongsuwann Y, Tacharoenmueng R, Mundy LM. Echovirus type 11: outbreak of hand-foot-and-mouth disease in a Thai hospital nursery. Clin Infect Dis. Nov 1 2005;41(9):1361-2. [Medline].
Gelfand HM, Holguin AH, Marchetti GE, Feorino PM. A continuing surveillance of enterovirus infections in healthy children in six United States cities. I. Viruses isolated during 1960 and 1961. Am J Hyg. Nov 1963;78:358-75. [Medline].
Wilfert CM, Lauer BA, Cohen M, Costenbader ML, Myers E. An epidemic of echovirus 18 meningitis. J Infect Dis. Jan 1975;131(1):75-8. [Medline]. [Full Text].
Marier R, Rodriguez W, Chloupek RJ, Brandt CD, Kim HW, Baltimore RS, et al. Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am J Dis Child. Mar 1975;129(3):321-5. [Medline].
Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. Jul 2006;50(7):2409-14. [Medline].
Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. Jan 1994;89(1):252-7. [Medline].
Bell EJ, Grist NR. ECHO viruses, carditis, and acute pleurodynia. Am Heart J. Jul 1971;82(1):133-5. [Medline].
Bultmann BD, Eggers HJ, Galle J. Age dependence of paralysis induced by echovirus type 9 in infant mice. J Infect Dis. Jun 1983;147(6):999-1005. [Medline].
CDC. Outbreak of aseptic meningitis associated with multiple enterovirus serotypes--Romania, 1999. MMWR Morb Mortal Wkly Rep. Jul 28 2000;49(29):669-71. [Medline].
Committee on the ECHO Viruses. ENTERIC cytopathogenic human orphan (ECHO) viruses. Science. Dec 16 1955;122(3181):1187-8. [Medline].
Crennan JM, Van Scoy RE, McKenna CH. Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature. Am J Med. Jul 1986;81(1):35-42. [Medline].
Hadfield MG, Seidlin M, Houff SA. Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin. J Neuropathol Exp Neurol. Sep 1985;44(5):520-9. [Medline].
Hall CB, Cherry JD, Hatch MH. The return of Boston exanthem. Echovirus 16 infections in 1974. Am J Dis Child. Mar 1977;131(3):323-6. [Medline].
Haynes RE, Cramblett HG, Kronfol HJ. Echovirus 9 meningoencephalitis in infants and children. JAMA. Jun 2 1969;208(9):1657-60. [Medline].
Kaplan GJ, Clark PS, Bender TR. Echovirus type 30 meningitis and related febrile illness: epidemiologic study of an outbreak in an Eskimo community. Am J Epidemiol. Oct 1970;92(4):257-65. [Medline].
Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics. Apr 1980;65(4):725-6. [Medline].
Modlin JF, Polk BF, Horton P. Perinatal echovirus infection: risk of transmission during a community outbreak. N Engl J Med. Aug 13 1981;305(7):368-71. [Medline].
Spencer FJ. The devil and William Dabney. An epidemiological postscript. JAMA. Feb 21 1966;195(8):645-8. [Medline].
Wilfert CM, Buckley RH, Mohanakumar T. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. Jun 30 1977;296(26):1485-9. [Medline].

